| Dr Babafemi Babawande Pratt, MD, MPH | |
|
641 N New Ballas Rd, Creve Coeur, MO 63141-6713 | |
| (314) 648-0101 | |
| (314) 899-2715 |
| Full Name | Dr Babafemi Babawande Pratt |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 16 Years |
| Location | 641 N New Ballas Rd, Creve Coeur, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174773873 | NPI | - | NPPES |
| 451418YKQH | Other | TX | MEDICARE PTAN |
| 352731901 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Medical Center, Inc | Pueblo, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parkview Ancillary Services Corporation | 4385722511 | 267 |
News Archive
TRANSCEND SERVICES, INC., a leading provider of clinical documentation services to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2010.
Mindray DS USA, a Mindray Global Company, announces the launch of the company's new premium M7 ultrasound system in the United States. The M7 platform is based on breakthrough System On Chip (SOC) technology, bringing a new level of imaging performance to a compact portable system.
The health law returns to the Supreme Court next week when justices consider a challenge by two companies seeking relief from the contraceptive coverage requirement.
Researchers from Umea University in Sweden have discovered that the single-celled parasite causing African sleeping sickness has a defence mechanism against potential pharmaceuticals under development against the disease. The deadly parasite has an enzyme that can cleave and hence disarm adenosine analogue pharmaceuticals. This according to a study recently published in the Journal of Biological Chemistry.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
› Verified 2 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
TRANSCEND SERVICES, INC., a leading provider of clinical documentation services to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2010.
Mindray DS USA, a Mindray Global Company, announces the launch of the company's new premium M7 ultrasound system in the United States. The M7 platform is based on breakthrough System On Chip (SOC) technology, bringing a new level of imaging performance to a compact portable system.
The health law returns to the Supreme Court next week when justices consider a challenge by two companies seeking relief from the contraceptive coverage requirement.
Researchers from Umea University in Sweden have discovered that the single-celled parasite causing African sleeping sickness has a defence mechanism against potential pharmaceuticals under development against the disease. The deadly parasite has an enzyme that can cleave and hence disarm adenosine analogue pharmaceuticals. This according to a study recently published in the Journal of Biological Chemistry.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
› Verified 2 days ago
| Entity Name | Parkview Ancillary Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982878765 PECOS PAC ID: 4385722511 Enrollment ID: O20080429000248 |
News Archive
TRANSCEND SERVICES, INC., a leading provider of clinical documentation services to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2010.
Mindray DS USA, a Mindray Global Company, announces the launch of the company's new premium M7 ultrasound system in the United States. The M7 platform is based on breakthrough System On Chip (SOC) technology, bringing a new level of imaging performance to a compact portable system.
The health law returns to the Supreme Court next week when justices consider a challenge by two companies seeking relief from the contraceptive coverage requirement.
Researchers from Umea University in Sweden have discovered that the single-celled parasite causing African sleeping sickness has a defence mechanism against potential pharmaceuticals under development against the disease. The deadly parasite has an enzyme that can cleave and hence disarm adenosine analogue pharmaceuticals. This according to a study recently published in the Journal of Biological Chemistry.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
› Verified 2 days ago
| Entity Name | Modern Vascular Of Denver, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184279804 PECOS PAC ID: 2567895584 Enrollment ID: O20191205001894 |
News Archive
TRANSCEND SERVICES, INC., a leading provider of clinical documentation services to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2010.
Mindray DS USA, a Mindray Global Company, announces the launch of the company's new premium M7 ultrasound system in the United States. The M7 platform is based on breakthrough System On Chip (SOC) technology, bringing a new level of imaging performance to a compact portable system.
The health law returns to the Supreme Court next week when justices consider a challenge by two companies seeking relief from the contraceptive coverage requirement.
Researchers from Umea University in Sweden have discovered that the single-celled parasite causing African sleeping sickness has a defence mechanism against potential pharmaceuticals under development against the disease. The deadly parasite has an enzyme that can cleave and hence disarm adenosine analogue pharmaceuticals. This according to a study recently published in the Journal of Biological Chemistry.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Babafemi Babawande Pratt, MD, MPH 26500 Agoura Rd Ste 102-587, Calabasas, CA 91302-1952 Ph: (818) 880-8605 | Dr Babafemi Babawande Pratt, MD, MPH 641 N New Ballas Rd, Creve Coeur, MO 63141-6713 Ph: (314) 648-0101 |
News Archive
TRANSCEND SERVICES, INC., a leading provider of clinical documentation services to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2010.
Mindray DS USA, a Mindray Global Company, announces the launch of the company's new premium M7 ultrasound system in the United States. The M7 platform is based on breakthrough System On Chip (SOC) technology, bringing a new level of imaging performance to a compact portable system.
The health law returns to the Supreme Court next week when justices consider a challenge by two companies seeking relief from the contraceptive coverage requirement.
Researchers from Umea University in Sweden have discovered that the single-celled parasite causing African sleeping sickness has a defence mechanism against potential pharmaceuticals under development against the disease. The deadly parasite has an enzyme that can cleave and hence disarm adenosine analogue pharmaceuticals. This according to a study recently published in the Journal of Biological Chemistry.
Johns Hopkins scientists report they have developed an antibody against a specific cellular gateway that suppresses lung tumor cell growth and breast cancer metastasis in transplanted tumor experiments in mice, according to a new study published in the February issue of Nature Communications.
› Verified 2 days ago
Hannah-ngoc T Ha, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 12401 Olive Blvd Ste 202, Creve Coeur, MO 63141 Phone: 314-834-2888 Fax: 314-834-5212 | |
Dr. Michael George Vranich, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 11255 Ladue Rd, Creve Coeur, MO 63141 Phone: 314-614-5368 Fax: 941-254-7497 | |
Dr. Nicole Michelle Martinez, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 845 N New Ballas Ct Ste 360, Creve Coeur, MO 63141 Phone: 314-219-1247 |